Dimension Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Dimension Therapeutics, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$42.87 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-11-06
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-09-30 was -$13.38M.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-06-30 was -$11.27M.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$18.22M.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$15.39M.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$47.64M.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$32.03M, a 465.63% decline from fiscal 2014.
- Dimension Therapeutics, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $8.76M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$13.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$24.65M derived: sum of 2 quarters · filed 2017-11-06 | -$42.87M 10-Q · filed 2017-11-06 | -$58.27M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$11.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$29.50M 10-Q · filed 2017-08-08 | -$44.89M derived: sum of 3 quarters · filed 2017-08-08 | -$55.81M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$18.22M 10-Q · filed 2017-05-10 | -$33.61M derived: sum of 2 quarters · filed 2017-05-10 | -$44.54M derived: sum of 3 quarters · filed 2017-11-06 | -$56.53M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | -$15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$26.32M derived: sum of 2 quarters · filed 2017-11-06 | -$38.31M derived: sum of 3 quarters · filed 2017-11-06 | -$47.64M 10-K · filed 2017-03-09 |
| 2016-09-30 | -$10.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$22.91M derived: sum of 2 quarters · filed 2017-11-06 | -$32.25M 10-Q · filed 2017-11-06 | -$40.07M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$11.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$21.33M 10-Q · filed 2017-08-08 | -$29.14M derived: sum of 3 quarters · filed 2017-08-08 | -$38.92M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$9.34M 10-Q · filed 2017-05-10 | -$17.15M derived: sum of 2 quarters · filed 2017-05-10 | -$26.93M derived: sum of 3 quarters · filed 2017-05-10 | -$33.05M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$17.59M derived: sum of 2 quarters · filed 2017-03-09 | -$23.71M derived: sum of 3 quarters · filed 2017-03-09 | -$32.03M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$9.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$15.90M derived: sum of 2 quarters · filed 2016-11-10 | -$24.21M 10-Q · filed 2016-11-10 | -$25.86M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$6.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$14.44M 10-Q · filed 2016-08-11 | -$16.08M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2015-03-31 | -$8.31M 10-Q · filed 2016-05-12 | -$9.96M derived: sum of 2 quarters · filed 2017-03-09 | ||
| 2014-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $8.76M 10-K · filed 2017-03-09 | ||
| 2014-09-30 | $10.40M 10-Q · filed 2015-12-04 | |||
| 2013-12-31 | -$192.00K 10-K · filed 2016-03-24 |